KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.

Noboru YamamotoMiyako SatouchiToshihiko DoiYutaka FujiwaraNoriko YanagitaniYoshitaka KawaKiyotaka YohLance LeopoldMihaela MunteanuTakashi SawadaShirong HanKazuo NoguchiMakoto Nishio

Published in: Investigational new drugs (2024)

ClinicalTrials.gov , NCT02862457.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
open label
phase ii
locally advanced
placebo controlled
double blind
tyrosine kinase
squamous cell carcinoma
chemotherapy induced
randomized controlled trial
rectal cancer
radiation therapy
study protocol